One third of American adults use herbal
capsules, tinctures, or teas seeking to improve their health and alleviate
illness. Although widespread use of herbal products is relatively new
in the U.S., it represents a $4 billion market. In many other cultures,
notably Asian and Native American, herbal medicines have been successfully
used over the centuries. The World Health Organization estimates that
up to 80% of peoples in developing countries rely on indigenous traditional
medicines to meet health care needs (Blumenthal, 1996). Arthritis and
rheumatoid arthritis (RA) are diseases that have long been treated with
traditional herbal remedies, especially in the Asian cultures.
A joint research project conducted by Dr. Pannaman of
the Biology Department at NJCU and the author (Chemistry Dept.) is currently
underway to study the principle chemical components in several traditional
Chinese medicinal plants (TCM) used to treat arthritis or rheumatoid
arthritis. According to a report of traditional Chinese medicines, the
Chinese people appear to be a healthy population and seem to do as well
as those in the West in hospitals (Way, Liu, & Chen, 1996).
Arthritis is presently Americas number one cause
of disability, affecting more than forty million Americans (Foster,
1997). The conventional treatments for arthritis are aspirin, corticosteroids,
or nonsteroidal anti-inflammatory drugs (NSAIDS). However, undesirable
side effects of NSAIDS drugs appear after prolonged usage. As many as
25 percent of prescription drugs contain an ingredient derived from
higher plants. The replacement of many of the synthetic pharmaceutical
compounds by natural substances is desirable because plant extracts
are not subjected to the same rigorous testing procedures as synthetic
analogues and are affordable to a broad spectrum of the population.
Modified plant compounds proven to be effective against a particular
ailment can also be chemically synthesized and mass-produced by the
pharmaceutical industry. The synthesis of these compounds is important
from an ecological perspective because the targeted plants are spared
from over-exploitation and species endangerment.
Over a millennium, by trial, error, and serendipity, the
Chinese have recorded the biological action of thousands of plant, animal,
and mineral products. This has led to the use of a vast number of agents
to diagnose, cure, and alleviate symptoms of ailments and illnesses.
A Chinese medicinal information bank has been established showing a
total of 240 plant families, 1,544 genera, and 4,940 species of vascular
plants employed as medicines. Fifty-one percent of Chinese Solanaceae
species, 47 percent of Cucurbitaceae species, and 45 percent
of Rutaceae species are used in medicine (www.egregore.com/herb/ArthritisRheuma-
tism.htm; Lewis & Lewis, 1977). It is no wonder that the Chinese
people consume considerable quantities of herbal remedies, many of which
have been used for centuries. The problem is that ethnomedicines and
the scientific bases for how they work are not well understood.
The processes leading to inflammation are mediated by
a variety of signaling molecules produced by cells of the immune system
(Konig, Brom, Schonfeld, Knoller,& Stuning, 1987). Many Chinese
herbs are prescribed by traditional practitioners to alleviate the inflammation
associated with arthritis. We are using a Western approach to isolate
and identify anti-inflammatory agents from TCMs. The reason is that
a single component assures uniformity in response, minimizes drug interaction,
and provides clues to the synthesis of superior analogues. In short,
it allows us to specifically study what we think we are studying. One
must always keep in mind that a decoction of eight plants could contain
literally hundreds of different chemicals (Way, Liu, & Chen, 1996).
Much of this work involves fairly sophisticated, but routine,
chemical instrumentation. In the past three years, the chemistry department
has been equipping itself with the modern instrumentation that will
allow it to carry out research on TCMs. Some work has already been completed
on the isolation of chemical principles from two Chinese TCMs,
Chuan niu xi (Cyathula capitata) and Xi xian (Siegesbeckia
orientalis L.). These plants are used by Chinese physicians to treat
arthritis and rheumatoid arthritis (Duke & Ayensu, 1985).
|
GAS CHROMATOGRAM OF
SIEGESBECKIA ORIENTALIS L.
|
|
|
We have optimized the separation and purification
processes and are currently analyzing the plant extract fractions by
various analytical instrumental techniques. The purification is accomplished
by high-performance liquid chromatography (HPLC) which is used to separate
a complex mixture into individual pure compounds. Once this is done
(which is by no means a small feat), each individual chemical constituent
can be identified by various spectroscopic techniques.
A very powerful technique that we have been using is gas
chromatography-mass spectrometry (GC-MS). This technique separates components
of a mixture where they appear as individual peaks on a chromatogram
(shown below). The position is unique for a given chemical compound
and the height of each peak is proportional to the amount of substance
present. The chromatogram is from the plant Siegesbeckia orientalis
L. with over thirty compounds represented in the mass spectrum. Each
peak corresponds to a fragment-ion produced when a compound is bombarded
with excess energy and produces what is called a fragmentation pattern.
The numbers at the top of each peak correspond to unique fragment ions
produced by this process. The identification of a compound is obtained
from its overall mass spectral fragmentation pattern. Some of the individual
compounds have been identified from their mass spectrum. We are currently
working on the isolation of the individual compounds and will characterize
these by GC-MS and nuclear magnetic resonance (NMR) spectroscopy.1
|
MASS SPECTRUM OF THE
25.59 MIN PEAK OF SIEGESBECKIA ORIENTALIS L.
|
 |
A crucial area of this research is the testing of
these compounds for effectiveness in treating arthritis. This is not
easy because of the limitations imposed on using animal or human subjects
in biological assays. Recently, we have identified assays using animal
cell lines instead of live animal models. We plan to expand our research
efforts to include other Chinese, native American, and Indian medicinal
plants.2
The activity of NSAIDS arises from inhibition of the enzymes
cyclooxygenase 1 and 2 (COX-1 and COX-2) or the lipoxygenase enzymes
(LOX). The COX enzymes are responsible for the formation of prostaglandins
while the LOX enzymes initiates the leukotriene cascade from arachidonic
acid.
COX-2 is induced by inflammatory stimuli such as cytokines
(a protein) during the inflammatory process and is found mostly in cells
that respond to inflammatory signaling molecules (Raguenes-Nicol, et
al.,1999). It is believed that the gastrointestinal disturbances associated
with NSAIDS result from inhibition of COX-1. Drug development has been
directed toward finding drugs that are much more selective against the
COX-2 enzyme (Miller, 1999). The lipoxygenase (LOX) enzymes are also
implicated as an inflammatory component in disease states such as arthritis,
asthma, allergy, and various skin diseases (Maycock, Pong, Evans, &
Miller, 1989; Batt, 1992). Another important molecule recently associated
with the inflammatory process is nitric oxide (NO) via an inducible
form of the nitric oxide synthase (iNOS) enzyme. We are currently preparing
biological assays that will test the principle compounds isolated from
TCMs for toxicity and biological activity against the COX-2, LOX, and
iNOS enzymes leading to the inflammatory and arthritic process.
|
EICOSANOID METABOLIC
PARHWAYS
|
 |

Batt, D.G. (1992). 5-Lipoxygenase inhibitors
and their anti-inflammatory activities. Progress in Medicinal Chemistry,
29, 2-63.
Blumenthal, M. (1996). (Preface). In S. Foster, Herbs
for your health (pp.vi-vii). CO: Interweave Press.
Duke, J. A., & Ayensu, E.S. (1985). Medicinal
plants of China (Vol 2). Algonac, MI: Reference Publications.
Foster, S. (1997, February/March). No title. The
Herb Companion, 69.
Konig, W., Brom, J., Schonfeld, W., Knoller, J.,
& Stuning, M. (1987). Effect of tenoxicam and indometacin on the
release of histamine prostaglandin E2 and leukotrienes from various
cells. Arzeimittel Forschung/Drug Research, 37 (1), 296-299.
Lewis, W.H., & Lewis, M.P.F. (1977). Medical
botany. New York: Wiley.
Maycock, A.L.,Pong,S.,Evans,J.F., & Miller, D.K.
(1989). In J. Rokach (Ed.), Leukotrienes and lipoxygenases (pp.
143-208). Lusanne, Switzerland:Elsevier Press.
Medicinal Herbs Online. (No date). Arthritis/Rheumatism,
[Online]. Available: http://www.e gregore.com/herb/Arthritis Rheumatism.htm
[2000, March 6].
Miller, D.R.(1999). Treatment options for rheumatoid
arthritis. Drug Topics, 143(9), 53-62.
Raguenes-Nicol,C., RussoMarie,F., Domage, G.,
Diab, N., Solito, E., Dray, F., Garcia-Mace, J.L., & Streichenberger,
G. (1999). Anti-inflammatory mechanism of alminoprofen: Action on the
phospholipid metabolism pathway. Biochemical Pharmacology, 57,
422-443, 1999.
Way,E.L., Liu,Y.Q.,& Chen, C.F. (1996). Perspective
and overview of Chinese traditional medicine and contemporary pharmacology.
Progress in Drug Research, 47, 131-164.
1. Yamaguch, K. (1999, November 23). Enhancing
the chemistry curriculum, teaching and research capabilities by the
implementation of Fourier transform nuclear magnetic resonance (NPR)
spectroscopy. Grant proposal., New Jersey City University, Jersey
City, NJ, submitted to U.S. Department of Defense.
2. Yamaguchi, K. & Pannaman, L. (2000, January
9). Screening Chinese herbs for anti-rheumatic compounds. Grant
proposal, New Jersey City University, Jersey City, NJ, submitted to
U.S. Department of Health and Human Services (DHHS-PHS, AREA).